Home Healthcare Pharmaceuticals Direct-to-Consumer (DTC) Weight-Loss Medication Market

Direct-to-Consumer (DTC) Weight-Loss Medication Market Size, Share & Trends Analysis Report By Drug Type (Prescription Medications, OTC Medications, Herbal and Natural Supplements), By Route of Administration (Oral, Injectable, Others), By Distribution Channel (Online Pharmacies, Drug Stores & Retail Pharmacies, Direct Brand websites) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 24, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Direct-to-Consumer (DTC) Weight-Loss Medication Market, By Drug Type 2022-2034 (USD MILLION/ Units)
    1. Prescription Medications
      1. GLP-1 Receptor Agonists
      2. Lipase Inhibitors
      3. Combination Therapies
      4. Others
    2. OTC Medications
      1. Alli
      2. Caffeine-based Pills
      3. Appetite suppressants
      4. Others
    3. Herbal and Natural Supplements
  2. Direct-to-Consumer (DTC) Weight-Loss Medication Market, By Route of Administration 2022-2034 (USD MILLION/ Units)
    1. Oral
    2. Injectable
    3. Others
  3. Direct-to-Consumer (DTC) Weight-Loss Medication Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Online Pharmacies
    2. Drug Stores & Retail Pharmacies
    3. Direct Brand websites
  4. Regional Direct-to-Consumer (DTC) Weight-Loss Medication Market
    1. North America
      1. North America Direct-to-Consumer (DTC) Weight-Loss Medication Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
      2. North America Direct-to-Consumer (DTC) Weight-Loss Medication Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectable
        3. Others
      3. North America Direct-to-Consumer (DTC) Weight-Loss Medication Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Online Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Direct Brand websites
      4. U.S.
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      5. Canada
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
    2. Europe
      1. Europe Direct-to-Consumer (DTC) Weight-Loss Medication Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
      2. Europe Direct-to-Consumer (DTC) Weight-Loss Medication Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectable
        3. Others
      3. Europe Direct-to-Consumer (DTC) Weight-Loss Medication Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Online Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Direct Brand websites
      4. U.K.
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      5. Germany
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      6. France
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      7. Spain
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      8. Italy
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      9. Russia
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      10. Nordic
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      11. Benelux
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      12. Rest of Europe
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
    3. APAC
      1. APAC Direct-to-Consumer (DTC) Weight-Loss Medication Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
      2. APAC Direct-to-Consumer (DTC) Weight-Loss Medication Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectable
        3. Others
      3. APAC Direct-to-Consumer (DTC) Weight-Loss Medication Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Online Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Direct Brand websites
      4. China
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      5. Korea
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      6. Japan
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      7. India
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      8. Australia
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      9. Taiwan
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      10. South East Asia
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      11. Rest of Asia-Pacific
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
    4. Middle East and Africa
      1. Middle East and Africa Direct-to-Consumer (DTC) Weight-Loss Medication Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
      2. Middle East and Africa Direct-to-Consumer (DTC) Weight-Loss Medication Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectable
        3. Others
      3. Middle East and Africa Direct-to-Consumer (DTC) Weight-Loss Medication Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Online Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Direct Brand websites
      4. UAE
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      5. Turkey
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      6. Saudi Arabia
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      7. South Africa
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      8. Egypt
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      9. Nigeria
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      10. Rest of MEA
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
    5. LATAM
      1. LATAM Direct-to-Consumer (DTC) Weight-Loss Medication Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
      2. LATAM Direct-to-Consumer (DTC) Weight-Loss Medication Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectable
        3. Others
      3. LATAM Direct-to-Consumer (DTC) Weight-Loss Medication Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Online Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Direct Brand websites
      4. Brazil
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      5. Mexico
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      6. Argentina
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      7. Chile
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      8. Colombia
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
      9. Rest of LATAM
        1. Prescription Medications
          1. GLP-1 Receptor Agonists
          2. Lipase Inhibitors
          3. Combination Therapies
          4. Others
        2. OTC Medications
          1. Alli
          2. Caffeine-based Pills
          3. Appetite suppressants
          4. Others
        3. Herbal and Natural Supplements
        4. Oral
        5. Injectable
        6. Others
        7. Online Pharmacies
        8. Drug Stores & Retail Pharmacies
        9. Direct Brand websites
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.